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Background: Contraceptive use prevalence in Kenya is at 58% according to the 2014 Kenya Demographic Health 
Survey. Several factors lead to discontinuation and switch of contraceptives. Discontinuation rate as per the 
2008/2009 KDHS for one year was 35.8%.  
Objectives:  To find out the determinants of discontinuation and switching of hormonal and IUD contraceptive 
methods.  
Methodology: The study was a cross-sectional hospital based one, where data was collected by use of an interviewer 
administered questionnaire at Kenyatta National Hospital, where 400 women were interviewed. The data was then 
analyzed by use of the statistical software, SPSS Version 20.  
Results: The study population mainly comprised married women with a mean age of 31.45±6.40 years. Most women 
chose a contraceptive method which they perceived had the least adverse effects. Discontinuation rate by the time of 
study in the study population was 60.8%, with adverse effects as the most cited reason for discontinuation. The 
method of contraception and presence of co-morbidity were the factors associated with discontinuation of a 
contraceptive. Survival analysis showed that depot injection and Jadelle® (Levonorgestrel releasing implant 75mg) 
had the highest median months of use and Impanon® (Etonogestrel implant 68mg) the least. 
Conclusion: The reasons for discontinuation of contraceptive use include primarily concerns for adverse effects, use 
inconvenience, desire for pregnancy, contraceptive failure, and doctor’s advice. 
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1. Introduction 
Contraception is avoidance of pregnancy by different 
methods other than avoiding coitus or hysterectomy 
(Monga et al, 2011). A contraceptive is a drug or device 
that prevents or may prevent fertilization, thus 
preventing the formation of an embryo. An ideal 
contraceptive method should be easy to use, affordable, 
easily distributed, safe with no side effects, highly 
effective, rapidly reversible, widely available, 
acceptable, independent of intercourse, and requiring 
minimal monitoring during use (Kristen, 2013, Hatcher 
et al, 2007). However, there is no single method of 
contraceptive which will meet all the ideal 
characteristics. 
Contraceptives are of various classes based on their 
composition or mode of action. The available classes of 
contraceptives are hormonal contraceptives, 
intrauterine contraceptives, barrier methods, natural 
family planning methods and sterilization also known 
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as permanent methods of contraceptives (U.S Food & 
Drug administration, 2014). 
Contraceptive discontinuation and switching is common 
as the need for contraceptives may change with time. 
Several factors could lead to contraceptive 
discontinuation or switch to a different one. The factors 
include adverse drug events, health risks, contraceptive 
failure, need for pregnancy, infrequent sexual 
intercourse, menopause, need for a more effective 
method, use inconvenience, lack of access, 
unaffordability or opposition from one’s spouse 
(Hatcher et al, 2007; John, 2012; Hilary, 2009). A study 
done in Bangladesh showed that half of women who 
initiate use of a contraceptive method discontinue it  
within an year and slightly above of two third (69%) 
discontinue it within two years of use (Syeda et al, 
2007). According to the KDHS 2008/09, one year 
discontinuation rate in Kenya was 35.8%... 
The Kenya Demographic Health Survey of 2008/2009 
showed that contraceptive discontinuation rate for one 
year is 35.8%. The reasons for the discontinuation were 
not indicated. The prevalence of unintended pregnancy 
among married women is at 43%.  This could be 
attributed to the high discontinuation rate of 
contraceptives. An analysis of the 2003 Kenyan DHS 
showed that 50.7%  of the women who discontinued 
use of contraceptives were at risk of pregnancy three 
months after (John, 2012). Unwanted pregnancies 
contribute to large sizes of families which are not 
planned for and also illegal abortions which contribute 
to maternal mortalities. 
Studies on discontinuation of contraceptives have not 
been extensively done in Kenya. An analysis of the same 
was done on KDHS data for the year 2008/09 but it did 
not capture the reasons behind the discontinuation. 
There is no study that has been done locally to 
determine the factors for the discontinuation and 
switching of contraceptive methods from one to 
another. 
The study will seek to establish the common reasons as 
to why women on hormonal contraceptives and IUDs 
discontinue or switch to other methods. It will also seek 
to find out the rate of discontinuation and switch within 
the study period. This will create awareness on the 
common reasons why women discontinue or switch 
from these contraceptive methods. This may help in 
creation of policies and strategies on which 
contraceptives should be mostly availed, and in 
counseling during initiation in order to address these 
determinants. Addressing the issues that would lead to 
discontinuation of contraceptive use will ensure better 
use hence prevention of unwanted pregnancies, which 
in turn would lead to reduction in abortion cases and 
maternal mortality. The study may also inform policy on 
the management of adverse effects associated with the 
contraceptives leading to their discontinuation. 
2. Methodology 
2.1 Study Site, Study Design and Population 
The study was carried out at the Kenyatta National 
Hospital’s Specialized Reproductive Health Clinic where 
outpatient contraceptive services are offered. The study 
was a cross-sectional study which involved use of an 
interviewer administered questionnaire. This was 
carried out with the months of May and June 2015. The 
study population comprised of women aged 18-49 who 
were seeking contraceptive and reproductive health 
services within the study location. 
2.2 Inclusion and Exclusion Criteria 
Women of reproductive age (18-49 years), within the 
study location and on a contraceptive method within 
the study period, who consented to the study, were 
included. Women who were expectant, post-
menopausal or not on any hormonal or IUD methods of 
contraception and also women who did not consent to 
the study, were excluded from the study. 
2.3 Sample Size and Sampling Criteria 
The sample size calculation was based on the Kenya 
Demographic Health Survey of 2008/2009, where one 
year contraceptive discontinuation rate in Kenya was 
35.8 %. Fischer formula was applied, with confidence 
intervals set at 95% and degree of precision at 5%. The 
sample size was determined to be 400 women. 
Universal sampling method was applied whereby every 
woman who met the inclusion criteria was included in 
the study till sample size was achieved. 
2.4 Data Collection 
Clients were recruited within the Specialized 
Reproductive Health Clinic (Clinic 66), every Monday to 
Friday, between 8.00 am and 5.00 pm. The participants 
who met the inclusion criteria and gave consent were 
recruited to the study. A face to face interview using an 
interviewer administered questionnaire was conducted. 
The information recorded included socio-demographic 
information, contraceptive use, discontinuation and 
switch and reasons for discontinuation 
2.5 Data Analysis 
A database was created using Epi Info. Version 7, for 
storage of all the data collected. The data was then 
analyzed by use of SPSS software Version 20. Analysis of 
numerical data through descriptive and inferential 
statistics was done. Descriptive data analysis was 
determined for the various variables and it was 
presented as mean, mode, median, frequencies, ranges 
and percentile. Exploratory data analysis which 
involved regressing the independent variables such as 
the demographic data, adverse effects, affordability 
against the dependent variables which are 
discontinuation rates and switching.  
2.6 Ethical Consideration 
Approval to carry out the study was sought from the 
KNH/UON Ethics and Research Committee, which was 
done under reference number KNH-ERC/A/157. 
Permission was also sought from the nursing officer in-
charge of Clinic 66.  
Informed consent was sought from identified clients 
who met the inclusion criteria. Participants were 
required to consent in writing before being recruited to 
the study. 
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 3.  Results and Discussion 
3.1 Sample Characteristics 
The mean age of the participating clients was 31.45 
years with a range of 20 to 49 while the mean weight 
was 67.95 kg with a standard deviation of 11.76. This is 
a little different from the findings of KDHS 2014 where 
the highest percentage of those who participated was 
ages 25-29. This could probably be due to different 
study site and study demographics. The mean age is 
comparable to the findings of a study done at the 
Kenyatta National Hospital-Comprehensive Care Clinic 
(KNH-CCC), on contraceptive use among HIV infected 
women, where the mean age was 34 (Mutiso et al, 
2008). 
The respondents who were married were 93.3%, while 
the minority were either never married or 
separated/divorced (Table 1). This is comparable to 
the participants of the KDHS 2014 where majority were 
married and the minority were either 
divorced/separated or widowed. The respondents who 
had received secondary school education were 44%, 
31.8% had gone through tertiary education and 23.5% 
had only primary level education. Only 8% had not 
received any education. This is a little different with the 
findings of the KDHS 2014 where only 42.7% had 
secondary school or tertiary education. This can 
probably be attributed to the different study sites and 
study demographics where the KDHS study has a 
representative sample for the whole country while this 
study was only done in a clinic in KNH. 
The participants who were unemployed were 35.8%, 
33.1% were self-employed and 8.3 % were in informal 
employment which is similar to other studies (Mutiso et 
al, 2008). Majority of the women (65.3%) had 1-2 
children, while only 2% had more than 4 children; this 
is comparable to a similar study conducted at KNH 
where most participants had 1-2 children (Nkonge et al, 
2014). Most of the participants were Christians and 
only 0.8 % were Muslims and no other religion was 
represented, which is comparable to the KDHS 2014 
findings where majority of the participants, 91.45 % 
were Christians. 
Only 7.1% of the study participants had co-morbid 
conditions of which hypertension was the highest at 
3.0%, asthma at 1.75% and diabetes mellitus at 0.8%. 
This is similar to findings of a study done within KNH on 
knowledge of correct use among hormonal 
contraceptive users, which found the prevalence of 
hypertension among its participants at 2.5%, diabetes 
mellitus at 0.8% and asthma at 0.5% (Nkonge et al, 
2014). Data on co-morbidity is important in 
characterizing the population of study and also to 
determine how it affects the discontinuation of 
contraceptives. 
 
    Table 1: Socio-demographic Characteristics of the Study Population 
Characteristic Category Frequency % (n) 
Marital status Single 5.5  (22) 
Married 93.3 (373) 
Divorced/Separated 1.3 (5) 
Highest level of education None 0.8 (3) 
Primary 23.5 (94) 
Secondary 44.0 (176) 
Tertiary 31.8 (127) 
Employment status Unemployed 35.8 (143) 
Informal employment 8.3 (33) 
Formal employment 22.8 (91) 
Self-employed 33.1 (132) 
Parity 0 2.0 (8) 
1-2 65.3 (261) 
3-4 30.8 (123) 
>4 2.0 (8) 
Religious affiliation Christian 99.2 (395) 
Islam  0.8 (3) 
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3.2 History of contraceptive use 
Combined oral contraceptives were being used by 29% 
of the study participants at the time of the study, 25% 
were using depot injection while both implants and IUD 
were at 22% in usage. (Table 2).  This is quite different 
from the findings of the KDHS 2014 where oral 
contraceptive pills were being used by 8%, injectables 
usage was at 26.4%, implants at 9.9% and IUD at 3.4%. 
Other studies show injectables as the most used among 
the hormonal contraceptives, followed by oral 
contraceptive pills and then implants (Nkonge et al, 
2014). The disparity could be due to the different study 
locations and different study objectives. 
Table 2:  Current Contraceptives in Use 
Current contraceptive  n % 
Combined Oral pills 117 29% 
Depot injection 98 25% 
Jadelle 48 12% 
Implanon 39 10% 
IUD 89 22% 
 
Majority of the women, who were using combined oral 
contraceptives (65.5%), cited least adverse effects as 
the reason for choosing it and only 5.9% gave use 
convenience as a reason for choosing the method 
(Table 3). Other women who were using depot 
injection (43.9%), gave use convenience as the reason 
for choosing it and only 3.1% used it because it was 
most available or due to doctor’s advice. The implants, 
Jadelle® and Implanon® were mainly used due to use 
convenience. Most of the IUD users chose the method 
because of least adverse effects (59.3%). Other reasons 
given for choosing the current contraceptives in use 
included advice by their peers, most preferred by 
spouse among others. 
Least adverse effects were the major reason why most 
women chose their current method of contraception, 
which was followed by use convenience (Table 3). 
Affordability or availability of a contraceptive method 
was a very minor reason for choosing a certain method 
of contraception which could be due to the fact that 
Government facilities are the main sources of 
contraceptives in Kenya, which is given at a very 
subsidized cost (KDHS 2008/2009; Nkonge et al, 2014). 
The reasons for choosing current methods of 
contraception are similar to those given in other studies 
(Nkonge et al, 2014). 
 
Table 3: Reasons for Choosing the Contraceptive in Use 
Current 
contraceptive  
Most effective 
Use 
convenience 
Least 
adverse 
effects 
Most 
available/ 
affordable 
Doctor’s advice 
Others 
(specify) 
% (n) %(n) %(n) %(n) %(n) %(n) 
Oral pills 6.7(8) 5.9(7) 65.5(78) 5(6) 15.1(18) 0(0) 
Depot injection 7.1(7) 43.9(43) 40.8(40) 3.1(3) 3.1(3) 1(1) 
Jadelle 18.8(9) 47.9(23) 31.3(15) 0(0) 4.2(2) 0(0) 
Implanon 10.3(4) 64.1(25) 20.5(8) 0(0) 0(0) 2.6(1) 
IUD 6.6(6) 14.3(13) 59.3(54) 0(0) 19.8(18) 2.2(2) 
Total 8.8(35) 28(111) 49.2(195) 2.3(9) 10.4(41) 1(4) 
 
Table 4: Reasons for Discontinuing Previous Contraceptive Methods 
 
Adverse 
effects 
Contraceptive 
failure 
Desire for 
more 
children 
Inconvenient 
to use 
Spouse 
disapproval 
Not 
affordable/
available 
Doctor’s 
advice 
Other 
Method N n (%) n (%) n (%) n (%) n (%) n (%) n (%) 
Oral pills 63 (51%) 5 (4%) 6 (5%) 49 (40%) 0 (0%) 0 (0%) 0 (0%) 1 (1%) 
Depot inj. 75 (79%) 1 (1%) 8 (8%) 8 (8%) 0 (0%) 0 (0%) 0 (0%) 3 (3%) 
Jadelle 26 (76%) 0 (0%) 4 (12%) 1 (3%) 0 (0%) 0 (0%) 1 (3%) 2 (6%) 
Implanon 14 (78%) 1 (6%) 2 (11%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 1 (6%) 
IUD 9 (60%) 2 (13%) 4 (27%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
TOTAL 187 (65.4%) 9 (3.14%) 24 (8.4%) 58 (20.28%) 0(0%) 0(0%) 1(0.35%) 7(2.45%) 
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Among the interviewed women, 60.8% had used more 
than one contraceptive method by the time of the study. 
This is comparable to an analysis done from 60 
demographic and health survey; in 19 countries by 
WHO which found that 64% of women discontinue 
using reversible methods of contraceptives by 36th 
month (Mohammed et al, 2012). Another DHS analysis 
of 20 studies for the USAID found that discontinuation 
rate within the first year of use was 18-63% (Sarah et 
al, 2009). Other studies show similar discontinuation 
rates (Wethoff et al, 2007). 
3.3 Reasons For Discontinuing Contraceptive  
Majority of the women, who discontinued using a 
particular method of contraceptive, did so due to 
adverse effects. Among those who discontinued using 
depot injection, 79% did so due to adverse effects, the 
same as 78% of Implanon® users, 76% of Jadelle® 
users, 60% of IUD users and 51% of Oral pill users. 
None of those who discontinued use of the methods 
cited neither spousal disapproval nor 
affordability/unavailability as the reason for 
discontinuation and only 3% of those who discontinued 
use of Jadelle® gave doctor’s advice as the reason. Use 
inconvenience was never a reason among those who 
discontinued use of Implanon® or IUD, but was the 
reason among 40% of those who stopped using Oral 
pills (Table 4). 
The major reason that would make the women 
discontinue on their current contraceptive was adverse 
effects at 49.5%, followed by desire for more children at 
36.0%. Unaffordability or unavailability was never a 
reason that would make a woman discontinue their 
contraceptive method. 
3.4 Duration of Use Before Discontinuation 
Survival analysis was done as an alternative way to 
represent all-cause discontinuation of contraceptive 
use. The median length of use which represents the 
length of time by which half of the women have stopped 
using a certain contraceptive method was calculated for 
the four methods as shown in Table 5. Duration of use 
of the contraceptives varied across the methods. The 
longest users were the depot injection users, mean 
months of usage of 41 followed by oral pills and IUD 
users with mean months of usage at 32. Implanon® had 
the lowest mean months of usage which was at 16. 
Depot injection users indicated the longest mean 
months of intended use (86), when asked for how long 
they were intending to be on the current method of 
contraceptive. This was followed by IUD users who had 
mean months of intended use as 84. Implanon® users 
gave the lowest intended mean months of use, 52 
followed by oral pill users whose mean was 61. 
Methods of contraceptives used before the study and 
their use duration before discontinuation are presented 
in Table 6. Method 1 is the very first contraceptive 
method that the study participants used as reported in 
the interview, method 2 is the second method they use 
and for those who used more than two methods, 
method 3 is their third method of use. Women use Oral 
pills, depot injection and IUD for a longer period if it’s 
the very first method of contraception they are using 
than if it’s the second method of contraception. 
Impalnts (Jadelle® and Implanon®) were used for longer 
duration if they are used as second or third methods of 
contraception as compared to when they are use as the 
first method. 
When IUD is used as the first method of contraception, 
it had the highest median length of use (60 months), 
followed by Jadelle® while Implanon® had the least 
median length of use. Jadelle® had the highest length of 
use when used as a second method of contraception, 
followed by Implanon and Oral Contraceptive pills had 
the least median length of use. A WHO analysis of 
several DHS (including Kenya 2003 DHS) on causes and 
consequences of contraceptives discontinuation showed 
similar results with IUD having the highest median 
length of use (40 months) and depot injection the 
lowest, though it did not include implants (Jadelle® and 
Implanon®) in the study (Mohammed et al, 2012). This 
can be due to the fact that IUD is a long term method of 
contraception, and can be effective for over ten years 
once inserted. 
3.5 Factors influencing Discontinuation of 
Contraceptive Use 
Bivariate analysis was done through logistic regression, 
to determine how several factors affected the 
discontinuation of contraceptives. Marital status, level 
of education, religious affiliation, employment status 
and parity were all not associated with discontinuation 
of contraceptives. It was only co-morbidity and the 
method of contraception that were associated with 
discontinuation of contraceptive use (P-value = 0.001 & 
<0.0001 respectively). This is different from a similar 
study carried out in Pakistan in 2012, which showed 
that family size (parity) is strongly associated with 
discontinuation of contraception (Farwa, 2012). The 
difference in findings could be due to the different study 
populations and probably different study design and 
objectives.
      Table 5: Duration of Use of Current Contraceptives in Months 
Current contraceptive on use Mean Median Minimum Maximum 
Oral pills 32 13 1 144 
Depot injection 41 24 1 132 
Jadelle 27 24 2 96 
Implanon 16 12 1 60 
IUD 32 16 1 120 
 Maina et al, Afr. J. Pharmacol. Ther. 2016. 5(1): 28-34 
 
 
A KeSoBAP Publication ©2016. All rights reserved.  ISSN 2303-9841 
33 
Table 6: Previous use of contraceptives and their duration of use 
Duration of use (months) Oral pills 
Depot 
injection 
Jadelle Implanon IUD 
Method 1  Mean 31 25 36 15 44 
Median 12 12 36 10 60 
Minimum 1 3 4 2 8 
Maximum 120 120 96 36 72 
Standard Deviation 33 29 25 12 28 
Method 2  Mean 24 13 53 29 8 
Median 3 9 60 30 8 
Minimum 1 3 1 18 5 
Maximum 138 60 120 36 12 
Standard Deviation 50 14 44 9 3 
Method 3  Mean - - 72 - - 
Median - - 60 - - 
Minimum - - 36 - - 
Maximum - - 120 - - 
Standard Deviation - - 43 - - 
 
Multivariate analysis on model building showed that 
only co-morbidity had a significant association with 
discontinuation of the contraceptives, with a P=0.001 
and an Odds Ratio of 3.582 (1.637-7.840), which means 
that the presence of a co-morbid condition increases the 
odds of discontinuing a contraceptive method by 3.6 
times. 
4. Conclusion 
Multiple reasons for discontinuation of contraceptive 
use include primarily concerns for adverse effects, use 
inconvenience, desire to become pregnant, 
contraceptive failure, and doctor’s advice.  Spousal 
disapproval and unaffordability or unavailability are 
not determinants of discontinuation of contraception 
use. Presence of a co-morbid condition on the user and 
the method of contraception are the statistically 
significant factors when it comes to discontinuation of 
contraceptives. 
Reproductive Health programs that deal with 
contraceptives need to come up with more detailed 
programs that address the high levels of 
discontinuation of contraception use by women who are 
still in need. Family planning programmers and 
stakeholders need to identify women who strongly 
want to avoid pregnancy and find ways to help the 
couples successfully initiate and maintain appropriate 
contraceptive use. The factors underlying the 
discontinuations need to be addressed thoroughly 
during the inception of contraceptive services, and 
counseling continued at each visit for the services. 
Deliberate rigorous screening for comorbid conditions 
should be carried out regularly and the client advised 
accordingly by the medical personnel. 
More studies need to be done to determine the 
temporal relationship between hormonal contraceptive 
use and onset of the comorbid conditions. Larger 
studies on the adequacy of contraceptive services and 
client satisfaction with the methods also need to be 
carried out. Studies following those who discontinue 
use of contraceptives while still in need of the services 
need to be done to find out what the outcomes are. 
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